Cite
APA Citation
Kim, Y., Ortiz‐Romero, P., Pro, B., Sokol, L., Scarisbrick, J., Musiek, A., Vermeer, M., Dummer, R., Halwani, A., Fierro, M., Moriya, J., Leoni, M., & Bagot, M. (n.d.). tIME TO NEXT TREATMENT IN PATIENTS WITH PREVIOUSLY TREATED CUTANEOUS T‐CELL LYMPHOMA (CTCL) RECEIVING MOGAMULIZUMAB OR VORINOSTAT: A POST‐HOC ANALYSIS OF THE MAVORIC STUDY. Hematological oncology, 37, 285–286. http://access.bl.uk/ark:/81055/vdc_100086192555.0x000036